Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Salbutamol for Food-Induced Abdominal Pain
NCT05653024Phase 3Terminated
- Start
- Jul 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of salbutamol in food allergy. Started Jul 2023; status: terminated.
02
Drugs
salbutamol
03
Conditions
food allergy
Beyond the preview
Go deeper on NCT05653024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05653024.